Mol Cancer Ther (2023) 22 (12_Supplement): PR014.
The Blood Cancer Discovery Award for Outstanding Journal Article is awarded to the corresponding author of a peer-reviewed, original Research Article or Brief published within the previous two years ...
1Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. 2Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, ...
1OBI Pharma, Inc., Taipei, Taiwan.
Institute of TCM-X/MOE Key Laboratory of Bioinformatics, Bioinformatics Division, BNRist/Department of Automation, Tsinghua University, Beijing, China.
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland. 3Department of Urology, James Buchanan ...
In the original version of this article (1), the baseline patient characteristic “Not examined” in the Table 1 section “HER2 expression (IHC): central laboratory assessment” was incorrectly labeled ...
Cancer Res (2023) 83 (8_Supplement): LB031.
Cancer Research | 85 | 8_Supplement_1 | April 2025Journal Archive Cancer Research (1941-Present; volumes 1-current) Published twice monthly since 1987. From 1941-1986, published monthly. (ISSN ...
In 1978, a Cancer Research article by Dougherty and colleagues reported the first large-scale clinical trial of photodynamic therapy (PDT) for treatment of 113 cutaneous or subcutaneous lesions ...
1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. *Corresponding Author: Elizabeth S. Duke, Office of Oncologic Diseases, Center for Drug Evaluation ...
Search for other works by this author on: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results